IXICO plc (LON:IXI – Get Free Report)’s stock price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 11.66 and traded as low as GBX 10. IXICO shares last traded at GBX 10, with a volume of 55 shares.
IXICO Stock Performance
The company has a quick ratio of 4.90, a current ratio of 2.85 and a debt-to-equity ratio of 3.32. The stock has a market capitalization of £9.50 million, a PE ratio of -5.54, a PEG ratio of -0.38 and a beta of 0.86. The firm has a 50 day moving average price of GBX 11.34 and a 200-day moving average price of GBX 11.66.
IXICO (LON:IXI – Get Free Report) last posted its quarterly earnings results on Tuesday, December 9th. The company reported GBX (1.85) EPS for the quarter. IXICO had a negative net margin of 31.10% and a negative return on equity of 19.14%. Research analysts expect that IXICO plc will post -289.3584879 EPS for the current fiscal year.
IXICO Company Profile
IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.
By unlocking valuable insights into drug safety and efficacy, IXICO has built a global reputation and 20-year track record as an end-to-end Imaging Contract Research Organisation (iCRO) managing and analysing neurological clinical trials.
Read More
- Five stocks we like better than IXICO
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Trump just signed it
- Trade this between 9:30 and 10:45 am EST
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- The $650 Million Bet on AI’s Future
Receive News & Ratings for IXICO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IXICO and related companies with MarketBeat.com's FREE daily email newsletter.
